BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
DHSC is conducting a market engagement exercise to understand more about the companies and services in the UK that can, or that are seeking to produce, distribute, supply and store different formulations of naloxone and of other drugs that can reverse the effect of an opioid overdose or of drugs taken with opioids.
The outcome of the market engagement will inform decisions around potential future procurement and storage of buffer stock as well as providing information on how the market could meet a potential increase in demand across the UK.
For avoidance of doubt this is not a call for competition, the purpose is to seek feedback from the market that may inform the final specification and/or procurement approach to the goods and services.
No supplier information available.